MARKET

ENVB

ENVB

Enveric Biosciences Inc
NASDAQ
2.370
-0.260
-9.89%
After Hours: 2.400 +0.03 +1.27% 19:45 02/06 EST
OPEN
2.580
PREV CLOSE
2.630
HIGH
2.590
LOW
2.140
VOLUME
84.34K
TURNOVER
--
52 WEEK HIGH
54.00
52 WEEK LOW
2.140
MARKET CAP
3.30M
P/E (TTM)
-0.0250
1D
5D
1M
3M
1Y
5Y
1D
Enveric Biosciences Expands At-The-Market Equity Offering Capacity
TipRanks · 1d ago
Enveric Biosciences kündigt Aktienplatzierung im Volumen von 1,35 Millionen US-Dollar an
Reuters · 1d ago
ENVERIC BIOSCIENCES: MAY OFFER & SELL CO'S COMMON STOCK HAVING AN AGGREGATE OFFERING PRICE OF UP TO $1.3 MLN FROM TIME TO TIME THROUGH WAINWRIGHT
Reuters · 1d ago
Weekly Report: what happened at ENVB last week (0126-0130)?
Weekly Report · 5d ago
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
TipRanks · 01/29 15:30
Enveric Biosciences Subsidiary Licenses Its U.S. Trademark Portfolio For RCANN To TOTEC Pharma
Benzinga · 01/29 13:06
Enveric Biosciences Licenses RCANN Trademark Portfolio to TOTEC Pharma
Reuters · 01/29 13:02
ENVERIC BIOSCIENCES EXPANDS COLLABORATION WITH TOTEC PHARMA THROUGH TRADEMARK LICENSE AND OPTION
Reuters · 01/29 13:00
More
About ENVB
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Webull offers Enveric Biosciences Inc stock information, including NASDAQ: ENVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENVB stock methods without spending real money on the virtual paper trading platform.